Pharmacy Benefit Manager Reform

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The spread: pilot study of an undocumented source of pharmacy benefit manager revenue.

OBJECTIVE To document the difference between what pharmacy benefits management companies (PBMs) charge employers and what they pay dispensing pharmacies for the drug ingredient portion of prescription transactions (the "spre DESIGN Descriptive, cross-sectional study. PARTICIPANTS Two large employer groups, each of which used a different PBM, and six independent community pharmacies particip...

متن کامل

Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data

BACKGROUND Observational data are increasingly being used for pharmacoepidemiological, health services and clinical effectiveness research. Since pharmacies first introduced low-cost prescription programs (LCPP), researchers have worried that data about the medications provided through these programs might not be available in observational data derived from administrative sources, such as payer...

متن کامل

Accuracy of pharmacy benefit manager medication formularies in an electronic health record system and the Epocrates mobile application.

BACKGROUND Physicians commonly use formulary medication coverage information generated by electronic heath records (EHRs) and the Epocrates mobile drug database application when making medication selection decisions. Nonformulary selections may lead to higher out-of-pocket patient costs and nonadherence with prescribed regimens. Nonformulary selections also contribute to higher overall health p...

متن کامل

Pharmacy benefit spending on oral chemotherapy drugs.

BACKGROUND Pharmacy benefits have historically excluded injectable drugs, resulting in coverage of injectable drugs under the medical benefit. High-cost biologics and other new drug therapies are often injectables and therefore have not presented cost threats to pharmacy benefits. The U.S. Food and Drug Administration approval of capecitabine, an oral form of fluorouracil, in 1998, and imatinib...

متن کامل

Pharmacy benefit managers: a model for Medicare?

This issue brief uses large employer experiences with pharmacy benefit managers (PBMs) to shed light on their potential as Medicare outpatient drug benefit administrators. PBM management techniques and typical employer approaches are discussed, as well as employer perspectives on PBM strengths and weaknesses and lessons learned. Considerations for Medicare policy are also examined. Information ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: JAMA

سال: 2019

ISSN: 0098-7484

DOI: 10.1001/jama.2019.7104